Akouos, Inc. (AKUS)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Emmanuel J. Simons
Employees:
100
645 SUMMER STREET, SUITE 200, BOSTON, MA 02210
857-245-5715

Akouos, Inc. is developing gene therapies to restore, improve, and preserve physiologic hearing. Its lead product candidate is AK-OTOF, a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. The company was incorporated in 2016 and is based in Boston, Massachusetts.

Data derived from most recent annual or quarterly report
Market Cap 459.967 Million Shares Outstanding34.61 Million Avg 30-day Volume 592.814 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.54
Price to Revenue0.0 Debt to Equity0.0 EBITDA-71.228 Million
Price to Book Value1.9131 Operating Margin0.0 Enterprise Value190.713 Million
Current Ratio11.393 EPS Growth0 Quick Ratio11.267
1 Yr BETA 0.9045 52-week High/Low 13.6 / 2.32 Profit Margin0.0
Operating Cash Flow Growth-52.1171 Altman Z-Score3.9602 Free Cash Flow to Firm 0
View SEC Filings from AKUS instead.

View recent insider trading info

Akouos, Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding AKUS (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AKUS

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2022-12-02 by WALKER PAUL EDWARD
  • 4: filed on 2022-12-02 by SONSINI PETER W.
  • 4: filed on 2022-12-02 by SANDELL SCOTT D
  • 4: filed on 2022-12-02 by MATHERS EDWARD T
  • 4: filed on 2022-12-02 by MAKHZOUMI MOHAMAD
  • 4: filed on 2022-12-02 by FLORENCE ANTHONY A. JR.
  • 4: filed on 2022-12-02 by CHANG CARMEN
  • 4: filed on 2022-12-02 by BEHBAHANI ALI
  • 4: filed on 2022-12-02 by BASKETT FOREST
  • 4: filed on 2022-12-02 by NEW ENTERPRISE ASSOCIATES 16, L.P.

    • Events (8k)

  • 8-K: filed on 2022-12-01:
    Item 1.02: Termination of a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 3.03: Material Modifications to Rights of Security Holders
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-11-14:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-18:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-15:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-26:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2022-06-27:
    Item 5.07: Submission of Matters to a Vote of Security Holders
  • 8-K: filed on 2022-05-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-03-29:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-11-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2021-08-12:
    Item 2.02: Results of Operations and Financial Condition
    Item 9.01: Financial Statements and Exhibits

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    SATO VICKI L

    • Director
    		 0 2022-12-01 2

    MATHERS EDWARD T

    • Director
    		 0 2022-12-01 2

    RAMASASTRY SAIRA

    • Director
    		 0 2022-12-01 2

    MINEGISHI SACHIYO CHIEF FINANCIAL OFFICER

    • Officer
    		 0 2022-12-01 1

    KEARNY ACQUISITION CORP

    ELI LILLY & CO

    • 10% Owner
    		 100 2022-11-30 2

    5AM VENTURES V, L.P.

    5AM PARTNERS V, LLC

    5AM OPPORTUNITIES I, L.P.

    5AM OPPORTUNITIES I (GP), LLC

    ROCKLAGE SCOTT M

    SCHWAB ANDREW J.

    • 10% Owner
    		 0 2022-11-30 1

    SANDELL SCOTT D

    • 10% Owner
    		 0 2022-11-30 1

    BASKETT FOREST

    • 10% Owner
    		 0 2022-11-30 1

    WALKER PAUL EDWARD

    • 10% Owner
    		 0 2022-11-30 1

    SONSINI PETER W.

    • 10% Owner
    		 0 2022-11-30 1

    FLORENCE ANTHONY A. JR.

    • 10% Owner
    		 0 2022-11-30 1

    TZIANABOS ARTHUR

    • Director
    		 0 2022-11-30 2

    PRESTON HEATHER

    • Director
    		 0 2022-11-30 2

    BEHBAHANI ALI

    • 10% Owner
    		 0 2022-11-30 1

    MAKHZOUMI MOHAMAD

    • 10% Owner
    		 0 2022-11-30 1

    PARMAR KUSH

    • Director
    • 10% Owner
    		 0 2022-11-30 2

    NEW ENTERPRISE ASSOCIATES 16, L.P.

    NEA PARTNERS 16, L.P.

    NEA 16 GP, LLC

    • 10% Owner
    		 0 2022-11-30 1

    CHANG CARMEN

    • 10% Owner
    		 0 2022-11-30 1

    MCKENNA MICHAEL JOHN CHIEF MEDICAL OFFICER

    • Officer
    		 0 2022-11-30 1

    SIMONS EMMANUEL CHIEF EXECUTIVE OFFICER

    • Officer
    • Director
    		 0 2022-11-30 1

    WELLMAN JENNIFER ANNE CHIEF OPERATING OFFICER

    • Officer
    		 0 2022-11-30 1

    SMITH CHRISTOPHER M

    • Director
    		 16,000 2022-06-23 1

    ROBINSON GREGORY SCOTT CHIEF SCIENTIFIC OFFICER

    • Officer
    		 0 2021-02-15 0

    NOVARTIS BIOVENTURES LTD

    NOVARTIS AG

    • FORMER 10% OWNERFORMER 10% OWNER
    		 No longer subject to file 2020-06-30 0

    SOFINNOVA VENTURE PARTNERS X, L.P.

    SOFINNOVA MANAGEMENT X, L.L.C.

    HEALY JAMES

    KATABI MAHA

    POWELL MICHAEL

    • 10% Owner
    		 No longer subject to file 2020-06-30 0

    MAKOWER JOSHUA

    • 10% Owner
    		 4,294,207 2020-06-30 0

    RA CAPITAL MANAGEMENT, L.P.

    RA CAPITAL HEALTHCARE FUND LP

    RA CAPITAL NEXUS FUND, L.P.

    KOLCHINSKY PETER

    SHAH RAJEEV M.

    • 10% Owner
    		 No longer subject to file 2020-06-30 0

    CORMORANT ASSET MANAGEMENT, LP

    CHEN BIHUA

    CORMORANT GLOBAL HEALTHCARE MASTER FUND, LP

    CORMORANT PRIVATE HEALTHCARE FUND II, LP

    • Director
    • 10% Owner
    • FORMER 10% OWNER
    		No longer subject to file 2020-06-30 0

    ECOR1 CAPITAL, LLC

    • 10% Owner
    		 No longer subject to file 2020-06-30 0

    PARTNERS INNOVATION FUND II, L.P.

    • 10% Owner
    		 No longer subject to file 2020-06-30 0

    PIVOTAL BIOVENTURE PARTNERS FUND I, L.P.

    PIVOTAL BIOVENTURE PARTNERS FUND I G.P., L.P.

    • 10% Owner
    		 No longer subject to file 2020-06-30 0

    PARTNERS INNOVATION FUND, LLC

    • 10% Owner
    		 No longer subject to file 2020-06-30 0

    MARSHFIELD ADVISERS LLC

    • 10% Owner
    		 No longer subject to file 2020-06-30 0

    SOFINNOVA VENTURE PARTNERS X, L.P.

    SOFINNOVA MANAGEMENT X, L.L.C.

    HEALY JAMES

    POWELL MICHAEL

    • 10% Owner
    		 0 2020-06-25 0

    OZDEN RABIA GURSES CHIEF DEVELOPMENT OFFICER

    • Officer
    		 0 2020-06-25 0

    MASSACHUSETTS EYE & EAR INFIRMARY

    • 10% Owner
    		 118,635 2020-06-25 0

    LONZA HOUSTON, INC.

    • 10% Owner
    		 118,635 2020-06-25 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    AKOUOS INC AKUS 2022-12-01 22:15:03 UTC 3.2276 0.5924 200000
    AKOUOS INC AKUS 2022-12-01 21:45:03 UTC 3.2235 0.5965 200000
    AKOUOS INC AKUS 2022-12-01 21:15:03 UTC 3.2235 0.5965 200000
    AKOUOS INC AKUS 2022-12-01 20:45:03 UTC 3.2235 0.5965 200000
    AKOUOS INC AKUS 2022-12-01 20:15:04 UTC 3.2235 0.5965 200000
    AKOUOS INC AKUS 2022-12-01 19:45:04 UTC 3.2235 0.5965 200000
    AKOUOS INC AKUS 2022-12-01 19:15:03 UTC 3.2235 0.5965 200000
    AKOUOS INC AKUS 2022-12-01 18:45:03 UTC 3.2235 0.5965 200000
    AKOUOS INC AKUS 2022-12-01 18:15:04 UTC 3.2235 0.5965 200000
    AKOUOS INC AKUS 2022-12-01 17:45:03 UTC 3.2235 0.5965 200000
    AKOUOS INC AKUS 2022-12-01 17:15:03 UTC 3.2235 0.5965 200000
    AKOUOS INC AKUS 2022-12-01 16:45:04 UTC 3.2276 0.5924 200000
    AKOUOS INC AKUS 2022-12-01 16:15:04 UTC 3.2276 0.5924 200000
    AKOUOS INC AKUS 2022-12-01 15:45:03 UTC 2.9335 0.8865 200000
    AKOUOS INC AKUS 2022-12-01 15:15:03 UTC 2.9335 0.8865 200000
    AKOUOS INC AKUS 2022-12-01 14:45:04 UTC 2.9335 0.8865 200000
    AKOUOS INC AKUS 2022-12-01 14:15:03 UTC 2.9335 0.8865 200000
    AKOUOS INC AKUS 2022-12-01 13:45:03 UTC 3.117 0.703 200000
    AKOUOS INC AKUS 2022-12-01 13:15:03 UTC 3.117 0.703 200000
    AKOUOS INC AKUS 2022-12-01 12:45:03 UTC 3.117 0.703 200000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments